ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 6

High Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth

Joyce Chang1,2, David Mandell3 and Andrea Knight4,5,6, 1Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Psychiatry and Pediatrics, Center for Mental Health Policy and Services Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 4Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 5Center for Pediatric Clinical Effectiveness & PolicyLab, Philadelphia, PA, 6Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Adolescent patients, diagnosis, Health Care, Pediatric rheumatology and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, May 19, 2017

Title: Plenary Abstract Session 2

Session Type: Abstract Submissions

Session Time: 2:00PM-3:00PM

Background/Purpose: Childhood-onset SLE is associated with high risk for organ damage, which may be mitigated by early diagnosis and treatment. To identify points of health care interaction for potential intervention, we compared pre-diagnosis health care utilization patterns of youth with SLE to those of controls.

Methods: Using US administrative claims (OPTUM) from 2000 to 2013, we identified 682 youth ages 10-24 years with an incident diagnosis of SLE (≥3 International Classification of Diseases, Ninth Revision codes for SLE 710.0, each >30 days apart) and 1,364 controls, matched 2:1 by age and sex. We compared the incidence of ambulatory, emergency and inpatient visits one year before SLE diagnosis, and the frequency of primary diagnosis codes. We examined associations of SLE subject characteristics with pre-diagnosis utilization.

Results:  Youth with SLE had significantly more visits in the year preceding diagnosis than controls across ambulatory (IRR 2.48, p<0.001), emergency (IRR 3.42, p<0.001) and inpatient settings (IRR 3.02, p<0.001) (Fig 1). The differences increased as diagnosis approached (Fig 2). Inpatient utilization was greater for SLE subjects with subsequent seizure/stroke and nephritis. Fever, venous thromboembolism, thrombocytopenia, chest pain and acute kidney failure were the most frequent diagnoses in acute care settings. The presence of a psychiatric diagnosis prior to SLE diagnosis was most strongly associated with increased utilization across all settings (Table).

Conclusion: Youth with SLE use significantly more health care in the year preceding diagnosis than peers without SLE, suggesting opportunities for earlier diagnosis, especially among those with neuropsychiatric or renal manifestations.


Disclosure: J. Chang, None; D. Mandell, None; A. Knight, None.

To cite this abstract in AMA style:

Chang J, Mandell D, Knight A. High Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/high-health-care-utilization-preceding-diagnosis-of-systemic-lupus-erythematosus-in-youth/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-health-care-utilization-preceding-diagnosis-of-systemic-lupus-erythematosus-in-youth/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology